Chito Zulueta was appointed president of emerging markets at Eli Lily & Co. in 2014.
We published an article on the ecosystem for life science innovation in China on MedidataVoice in Forbes this week, and there is plenty more to cover.
With the recently concluded gathering in Nice, France, I have now attended three Medidata User Group (MUG) meetings this year. The Americas and European user meetings—A-MUG and E-MUG—were great fun and informative as always, but the one that really piqued my interest was the inaugural China MUG (C-MUG) held in Beijing this September. The sheer growth of clinical research activity in China and the willingness and receptivity of the many clinical trialists to embrace eClinical technologies is striking. The folks I met occupied the full spectrum of eClinical adoption. They ranged from those taking their first tentative steps transitioning from paper to electronic CRFs to those at the cutting-edge of newer, innovative approaches to running clinical trials with cloud-based platforms and processes driven by best practices.